Equine Pharmaceuticals
DOLOREX® (butorphanol tartrate injection)
Product Description
DOLOREX® (butorphanol tartrate) is indicated for the relief of pain associated with colic in adult horses and yearlings. Clinical studies in the horse have shown that butorphanol tartrate alleviates abdominal pain associated with torsion, impaction, intussusception, spasmodic and tympanic colic, and postpartum pain. WARNING: FOR USE IN HORSES ONLY. NOT FOR USE IN HORSES INTENDED FOR FOOD. CAUTION: DOLOREX, a potent analgesic, should be used with caution with other sedative or analgesic drugs as these are likely to produce additive effects. There are no well controlled studies using butorphanol in breeding horses, weanlings, and foals. Therefore the drug should not be used in these groups. ADVERSE REACTIONS: In clinical trials in horses, the most commonly observed side effect was slight ataxia which lasted 3 to 10 minutes. Marked ataxia was reported in 1.5% of the 327 horses treated. Mild sedation was reported in 9% of the horses.
| Product Name | Pkg Size | GTIN#/UPC# | UIN# |
|---|---|---|---|
| DOLOREX® | 1 x 50ml | 021784722506 | 017070 |
IMPORTANT SAFETY INFORMATION:
Not for use in horses intended for food. There are no known contraindications to this drug when used as directed. Intra-arterial injection should be avoided to avoid adverse reactions. Do not use in horses showing hypersensitivity to flunixin meglumine. The effect of Banamine Injectable Solution on pregnancy has not been determined. Concomitant use of Banamine Injectable Solution with other anti-inflammatory drugs such as NSAIDs and corticosteroids should be avoided or closely monitored. In horses, rare instances of anaphylactic-like reactions some of which have been fatal have been reported, primarily following intravenous use.